Study Highlights New Potential Targets for Huntington's Disease
By Sharon Kingman
Wednesday, February 22, 2012
LONDON A type of drug that is already being evaluated as a treatment for Huntington's disease could have a valuable side effect that would also help reduce the progress of the condition, a new study suggested.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.